Replies to post #174937 on Biotech Values

[DewDiligence]

OHRP will announce phase-2 Squalamine data tomorrow (CC at 8:30am ET):

http://finance.yahoo.com/news/ohr-pharmaceutical-host-conference-call-203000725.html

I'll be astonished if Squalamine eye drops show bona fide efficacy in wet AMD.